Cited by 175Nitric Oxide and Endothelin EffectsLipoproteins and Cardiovascular HealthCholesterol and Lipid Metabolism

The DOI matches its Crossref record; 81 of the 82 references it cites were found in a registry or an index.

Effects of HMG-CoA Reductase Inhibitors on Endothelial Function: Role of Microdomains and Oxidative Stress

Open access

Mason, R. Preston, Walter, Mary F., Jacob, Robert F.·2004·Circulation

Open this paper in CoChat — free account Open PDF

Abstract

Certain pleiotropic activities reported for 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are related to reductions in cellular cholesterol biosynthesis and isoprenoid levels. In endothelial cells, these metabolic changes contribute to favorable effects on nitric oxide (NO) bioavailability. Given the essential role of NO in preserving vascular structure and function, this effect of statins is of considerable therapeutic importance. Statins have been demonstrated to restore endothelial NO production by several mechanisms, including upregulating endothelial NO synthase (eNOS) protein expression and blocking formation of reactive oxygen species. In this article, we will discuss additional ways in which statins restore endothelial NO production and improve endothelial function. (1) Statins modulate membrane microdomain formation, resulting in reduced expression of proteins that specifically inhibit eNOS activation. (2) Statins reduce sterol biosynthesis, thus interfering with the formation of pathologic microdomains, including cholesterol crystalline structures. This observation has important implications for plaque stabilization, as these microdomains contribute to cholesterol crystal formation and endothelial apoptosis. Finally, (3) statins improve endothelial function by interfering with oxidative stress pathways through both enzymatic and nonenzymatic mechanisms. The relationships between membrane microdomains, cholesterol biosynthesis, and endothelial function will be discussed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/01.cir.0000129503.62747.03

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Functional rafts in cell membranes
Simons, K., & Ikonen, E. (1997) · Nature · doi:10.1038/42408 · Cited by 9,757
X-Ray Diffraction
Warren, Β. E. (1968) · Cited by 5,833
NAD(P)H Oxidase: Role in Cardiovascular Biology and Disease
Griendling, K. K., Sorescu, D., & Ushio-Fukai, M. (2000) · Circulation Research · doi:10.1161/01.res.86.5.494 · Cited by 2,886
Structure and Function of Sphingolipid- and Cholesterol-rich Membrane Rafts
Brown, D. A., & London, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000005200 · Cited by 2,344
Molecular Bases of the Acute Coronary Syndromes
Libby, P. (1995) · Circulation · doi:10.1161/01.cir.91.11.2844 · Cited by 2,029
Regulatory Functions of the Vascular Endothelium
Epstein, F. H., Vane, J. R., Änggård, E., & Botting, R. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230106 · Cited by 1,885
Upregulation of Endothelial Nitric Oxide Synthase by HMG CoA Reductase Inhibitors
Laufs, U., Fata, V. L., Plutzky, J., & Liao, J. K. (1998) · Circulation · doi:10.1161/01.cir.97.12.1129 · Cited by 1,837
Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice
Dráb, M., Verkade, P., Elger, M., Kasper, M. E., Löhn, M., Lauterbach, B., Menne, J., Lindschau, C., Mende, F., Luft, F. C., et al. (2001) · Science · doi:10.1126/science.1062688 · Cited by 1,555
Cholesterol and the cell membrane
Yèagle, P. L. (1985) · Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes · doi:10.1016/0304-4157(85)90011-5 · Cited by 1,492

Show all 82 references

Research works printed but not linked: 18

10.1161/atvb.19.8.1891 · DOI
1991, FASEB J, 5, A531.
1992, Comments Mol Cell Biophys, 8, 53
10.1161/circ.101.11.1261 · DOI
1989, Am J Physiol, 257, H170
10.1161/res.69.1.2054935 · DOI
1995, J Membr Biol, 143, 51
10.1161/atvb.17.7.1337 · DOI
10.1161/circ.91.11.2844 · DOI
1989, Am J Pathol, 134, 705
10.1161/atvb.18.3.423 · DOI
10.1161/atvb.17.11.2975 · DOI
10.1161/circ.98.25.2822 · DOI
10.1161/circ.99.15.2027 · DOI
10.1161/res.86.5.494 · DOI
10.1161/circ.97.12.1129 · DOI
10.1161/atvb.20.1.61 · DOI
10.1161/atvb.22.2.300 · DOI

Sorted by citations

Items 101–175 of 175

Possible Involvement of Akt Activity in Endothelial Dysfunction in Type 2 Diabetic Mice
Takenouchi, Y., Kobayashi, T., Matsumoto, T., & Kamata, K. (2008) · Journal of Pharmacological Sciences · doi:10.1254/jphs.fp0071684 · Cited by 20
Caveolin-1–eNOS/Hsp70 interactions mediate rosuvastatin antifibrotic effects in neonatal obstructive nephropathy
García, I. M., Mazzei, L. J., Benardón, M. E., Oliveros, L. B., Cuello-Carrión, F. D., Lorenzo, A. G., Manucha, W. A., & Vallés, P. G. (2012) · Nitric Oxide · doi:10.1016/j.niox.2012.05.006 · Cited by 18
Improvement of Antioxidant and Immune Status of Atherosclerotic Rats Adrenaline and Egg-Yolks -Induced Using Cardamom-Rhizome-Ethanolic-Extract: An Initial Study of Functional Food
Winarsi, H., Yuniaty, A., & Nuraeni, I. (2016) · Agriculture and Agricultural Science Procedia · doi:10.1016/j.aaspro.2016.02.147 · Cited by 17
Zebrafish as a Model for the Study of Lipid-Lowering Drug-Induced Myopathies
Dubińska–Magiera, M., Migocka-Patrzałek, M., Lewandowski, D., Daczewska, M., & Jagla, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115654 · Cited by 17
No effects of atorvastatin (10mg/d or 80mg/d) on nitric oxide, prostacyclin, thromboxane and oxidative stress in type 2 diabetes mellitus patients of the DALI study
Tsikas, D., Pham, V. V., Suchy, M.-T., van de Ree, M. A., Huisman, M. V., Frölich, J. C., & Princen, H. M. G. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.01.004 · Cited by 16
New advances in the role of JAK2 V617F mutation in myeloproliferative neoplasms
Zhang, Y., Zhao, Y., Liu, Y., Zhang, M., & Zhang, J. (2024) · Cancer · doi:10.1002/cncr.35559 · Cited by 15
Investigating the potential of statin medications as a nitric oxide (NO) release agent to decrease decompression sickness: A review article
Duplessis, C. A., & Fothergill, D. M. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.04.050 · Cited by 14
Effects of Atorvastatin and Insulin in Vascular Dysfunction Associated With Type 2 Diabetes
Sena, C. M., Matafome, P. N., Louro, T. M., Nunes, E., & Seiça, R. M. F. (2014) · Physiological Research · doi:10.33549/physiolres.932554 · Cited by 14
Statins?is there no end to their usefulness?
Wainwright, C. L. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.11.030 · Cited by 14
Effects of short-term anti-inflammatory therapy on endothelial function in patients with non-ST-segment elevation acute coronary syndrome
Chyrchel, M., Dudek, D., Rzeszutko, Ł., Dziewierz, A., Chyrchel, B., Rakowski, T., & Dubiel, J. S. (2010) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2009.11.001 · Cited by 13
Review: HMG CoA reductase inhibitors and renoprotection: the weight of the evidence
Kurukulasuriya, L. R., Athappan, G., Saab, G., Whaley‐Connell, A. T., & Sowers, J. R. (2007) · Therapeutic Advances in Cardiovascular Disease · doi:10.1177/1753944707082714 · Cited by 13
Novel applications of COX-2 inhibitors, metformin, and statins for the primary chemoprevention of breast cancer
Micallef, D. A., Micallef, S., Schembri-Wismayer, P., & Calleja‐Agius, J. (2016) · Journal of the Turkish-German Gynecological Association · doi:10.5152/jtgga.2016.15200 · Cited by 12
Effect of simvastatin on endothelial cell apoptosis mediated by Fas and TNF-α
Acquavella, N., Quiroga, M. F., Wittig, O., & Cardier, J. E. (2009) · Cytokine · doi:10.1016/j.cyto.2009.09.011 · Cited by 12
Nanomechanical testing of drug activities at the cellular level: Case study for endothelium-targeted drugs
Kołodziejczyk, A. M., Targosz‐Korecka, M., & Szymoński, M. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.06.007 · Cited by 11
Influence of pravastatin chitosan nanoparticles on erythrocytes cholesterol and redox homeostasis: An in vitro study
Harisa, G. I., Badran, M. M., Attia, S. M., Alanazi, F. K., & Shazly, G. A. (2015) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2015.10.016 · Cited by 11
Hypotensive effect of atorvastatin is not related to changes in inflammation and oxidative stress
Kuklińska, A. M., Mroczko, B., Musial, W. J., Sawicki, R., Kozieradzka, A., Usowicz-Szaryńska, M., Kamiński, K. A., Knapp, M., & Szmitkowski, M. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70348-0 · Cited by 10
Effects of simvastatin on CAT-1-mediated arginine transport and NO level under high glucose conditions in conditionally immortalized rat inner blood-retinal barrier cell lines (TR-iBRB)
Tun, T., & Kang, Y. (2017) · Microvascular Research · doi:10.1016/j.mvr.2017.01.002 · Cited by 10
Clinical Predictors of Atheroma Progression Despite Optimal Glycemic Control in Early-Stage Diabetic Patients with Coronary Artery Disease: Insight from the DIANA Study
Kataoka, Y., Yasuda, S., Miyamoto, Y., Sase, K., Kosuge, M., Kimura, K., Yoshimasa, Y., & Miyazaki, S. (2014) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.21089 · Cited by 10
Simvastatin pretreatment enhances ischemia-induced neovascularization and blood flow recovery in streptozotocin-treated mice
Huang, P., Chen, J.-Y., Chen, C., Chen, J., Lin, S., & Shih, C.-C. (2016) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2014.11.088 · Cited by 9
Croton schiedeanus Schltd prevents experimental hypertension in rats induced by nitric oxide deficit
González, M. T. P., Rodríguez, D. C., López, D. F., Castañeda, J. A., Buitrago, D. M., Suárez, L. E. C., & Guerrero, M. F. (2013) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s1984-82502013000400027 · Cited by 9
Neuronal marker recovery after Simvastatin treatment in dementia in the rat brain: In vivo magnetic resonance study
Klepochová, R., Lipták, B., Szomolányi, P., Vančová, O., Uličná, O., Sumbalová, Z., Kucharská, J., Dubovický, M., Trattnig, S., Liptaj, T., et al. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.02.016 · Cited by 9
Ezetimibe and Vascular Endothelial Function
Ikeda, S., & Maemura, K. (2010) · Current Vascular Pharmacology · doi:10.2174/157016111793744797 · Cited by 7
Statin use and peripheral blood progenitor cells mobilization in patients with multiple myeloma
Stravodimou, A., & Voutsadakis, I. A. (2013) · Clinical & Translational Oncology · doi:10.1007/s12094-013-1046-9 · Cited by 8
Simvastatin reverses the hypertension of heterozygous mice lacking cystathionine β-synthase and apolipoprotein A-I
Carnicer, R., Navarro, M. Á., Guillén, N., Arbonés-Mainar, J. M., Surra, J. C., Acı́n, S., & Osada, J. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0247-6 · Cited by 8
Effects of Nutritional and Excessive Levels of Selenium on Red Blood Cells of Rats Fed a High Cholesterol Diet
Harisa, G. I., Abo‐Salem, O. M., El‐Sayed, E. M., & Shazly, G. (2013) · Biological Trace Element Research · doi:10.1007/s12011-012-9588-1 · Cited by 8
Mevastatin increases eNO synthase expression and inhibits lipid peroxidation in human endothelial cells.
Schalkwijk, C. G., van Dam, B., Stehouwer, C. D. A., & van Hinsbergh, V. W. M. (2007) · PubMed · Cited by 8
Atherosclerosis: Pathologic Anatomy and Pathogenesis
Buja, L. M., & McAllister, H. A. (2007) · Springer eBooks · doi:10.1007/978-1-84628-715-2_76 · Cited by 8
Impact of statin on long-term outcome among patients with end-stage renal disease with acute myocardial infarction (AMI): a nationwide case–control study
Kuo, F. Y., Huang, W., Tang, P., Cheng, C.-C., Chiang, C., Lin, H.-C., Chuang, T.-J., Wann, S., Mar, G.-Y., Liu, C., et al. (2021) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2019-137292 · Cited by 7
Statin Overuse in Cerebral Ischemia Without Indications: Systematic Review and Annual US Burden of Adverse Events
Sung, E. M., & Saver, J. L. (2024) · Stroke · doi:10.1161/strokeaha.123.044071 · Cited by 7
Arginase, nitrates, and nitrites in the blood plasma and erythrocytes in hypertension and after therapy with lisinopril and simvastatin
Kaminskii, Y. G., Сусликов, А. В., Tikhonova, L. A., Galimova, M. K., Ermakov, G. L., Tsvetkov, V. D., & Kosenko, E. A. (2011) · Biology Bulletin · doi:10.1134/s1062359011050074 · Cited by 7
Fluvastatin attenuated the effect of expression of β1 integrin in PAN-treated podocytes by inhibiting reactive oxygen species
Liu, J., Zhang, B., Chai, Y., Xu, Y., Xing, C., & Wang, X. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2220-2 · Cited by 7
Differentially expressed genes in human peripheral blood as potential markers for statin response
Won, H., Kim, S. R., Bang, O. Y., Lee, S., Huh, W., Ko, J., Kim, H., McLeod, H. L., O’Connell, T. M., Kim, J., et al. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-011-0818-3 · Cited by 7
Scientific Rationale for Combination of a Calcium Channel Antagonist and an HMG-CoA Reductase Inhibitor
Mason, R. P. (2008) · Drugs · doi:10.2165/00003495-200868070-00001 · Cited by 7
Self-citation
Disaster epidemiology: prudent public health practice in the Pacific Islands.
Twum-Danso, N. A. Y. (2002) · PubMed · Cited by 6
Statin restores cardiac autonomic response to acute hypoxia in hypercholesterolaemia
Brasileiro‐Santos, M. S., Barreto-Filho, J. A. S., Santos, R. D., Chacra, A. P. M., Sangaleti, C. T., Alvez, G., Bezerra, O. C., Bortolotto, L. A., Irigoyen, M. C., & Consolim‐Colombo, F. M. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12177 · Cited by 5
Molecular Mechanisms of the Cardiotoxic Action of Anthracycline Antibiotics and Statin-Induced Cytoprotective Reactions of Cardiomyocytes
Владимировна, Т. Н., Геннадьевна, К. М., Babenko, O. A., & Lushnikova, E. L. (2021) · Biochemistry (Moscow) Supplement Series B Biomedical Chemistry · doi:10.1134/s1990750821020116 · Cited by 4
Hospitalised ischaemic cerebrovascular accident and risk factors in a primary care database
Martín‐Merino, E., Ruigómez, A., Johansson, S., & García‐Rodríguez, L. A. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2201 · Cited by 4
Senecio serratuloides extract prevents the development of hypertension, oxidative stress and dyslipidemia in nitric oxide-deficient rats
Tata, C. M., Sewani-Rusike, C. R., Oyedeji, O. O., Mahlakata, F., Shauli, M., & Nkeh-Chungag, B. N. (2020) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2018-0073 · Cited by 4
Efficacy of intensive lipid-lowering therapy with statins stratified by blood pressure levels in patients with type 2 diabetes mellitus and retinopathy: Insight from the EMPATHY study
Shinohara, K., Ikeda, S., Enzan, N., Matsushima, S., Tohyama, T., Funakoshi, K., Kishimoto, J., Itoh, H., Komuro, I., & Tsutsui, H. (2021) · Hypertension Research · doi:10.1038/s41440-021-00734-x · Cited by 4
Relationship between pre-stroke cardiovascular medication use and stroke severity
Desmaele, S., Cornu, P., Barbé, K., Brouns, R., Steurbaut, S., & Dupont, A. G. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-2001-1 · Cited by 4
The Combination of Elevated Triglycerides and Abnormal Fasting Glucose Increases Risk of Cerebral Infarction in Patients With Mild to Moderate Hypercholesterolemia
Nakagami, T., Nishimura, R., Sone, H., & Tajima, N. (2014) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248414537706 · Cited by 4
Erectile dysfunction: a marker of early coronary heart disease.
Vrentzos, G. E., Paraskevas, K. I., & Mikhailidis, D. P. (2007) · PubMed · Cited by 4
Statin-Mediated Modulation of Nrf2 Signaling: Mechanisms and Therapeutic Implications in Atherosclerosis
Marzoog, B. A., & Kopylov, F. Y. (2026) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm46903 · Cited by 5
Effectiveness of statin intensive therapy in type 2 diabetes mellitus with high visit-to-visit blood pressure variability
Ikeda, S., Shinohara, K., Enzan, N., Matsushima, S., Tohyama, T., Funakoshi, K., Kishimoto, J., Itoh, H., Komuro, I., & Tsutsui, H. (2021) · Journal of Hypertension · doi:10.1097/hjh.0000000000002823 · Cited by 3
Effects of HMG-CoA reductase inhibitors on blood coagulation and fibrinolytic regulation factors in the endothelial cell
YAMAZAKI, K., Morishita, E., Hirano, K., SEKINO, T., Yoshida, T., Hayashi, T., MIDATE, Y., Yamazaki, M., Asakura, H., Nakao, S., et al. (2006) · Japanese Journal of Thrombosis and Hemostasis · doi:10.2491/jjsth.17.454 · Cited by 3
Molecular mechanisms of the cardiotoxic action of anthracycline antibiotics and statin-induced cytoprotective reactions of cardiomyocytes
Владимировна, Т. Н., Геннадьевна, К. М., Babenko, O. A., & Lushnikova, E. L. (2020) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20206605357 · Cited by 3
Methyl β-cyclodextrin activates eNOS-cGMP pathway in endothelial cells
Park, K.-H., Kim, J., Noh, E., Yu, H., Kim, S. Y., Kim, S.-Z., Kim, S., & Chung, E. Y. (2013) · Molecular & Cellular Toxicology · doi:10.1007/s13273-013-0030-3 · Cited by 3
Potential role of statins and PPARs in rheumatoid arthritis
Douglas, K., Sattar, N. A., & Kitas, G. D. (2006) · Future Rheumatology · doi:10.2217/17460816.1.2.259 · Cited by 3
Outcomes after coronary angiography in individuals with elevated lipoprotein(a)
Supriami, K., Faaborg-Andersen, C. C., Cho, S. M. J., Tello-Ayala, J. R., Abou-Karam, R., Pomerantsev, E. V., Viscosi, V., Haidermota, S., Hornsby, W., Natarajan, P., et al. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf690 · Cited by 3
Influence of Simvastatin Chronotherapy on Erythrocytes Nitric oxide Synthase Activity
Harisa, G. I., Alanazi, F. K., Attia, S. M., & Omran, G. A. (2015) · International Journal of Pharmacology · doi:10.3923/ijp.2015.448.455 · Cited by 2
Effects of Oxidative Stress, Hyperglycemia, and Hypercholesterolemia on Membrane Structural Organization and the Interactions of Omega-3 Fatty Acids
Mason, R. P., & Jacob, R. F. (2017) · Springer series in biophysics · doi:10.1007/978-3-319-66601-3_3 · Cited by 3
Self-citation
Pharmacological interventions for treating dyslipidemia in patients with HIV infection
Martí-Carvajal, A. J., & Cruciani, M. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008869 · Cited by 2
Retracted
Chronic kidney disease as a cardiovascular risk state and considerations for the use of statins
McCullough, P. A., Rocher, L. R., Nistala, R., & Whaley‐Connell, A. T. (2008) · Journal of clinical lipidology · doi:10.1016/j.jacl.2008.06.008 · Cited by 2
Atorvastatin attenuates vascular remodelling in spontaneously hypertensive rats via the protein kinase D/extracellular signal‐regulated kinase 5 pathway
Yuan, H., Wang, D., Zhang, Y., & Geng, J. (2020) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13319 · Cited by 2
The Expanding Role of the HMG-CoA Reductase Inhibitor, The Most Widely Prescribed Drug in the World
Futterman, L. G., & Lemberg, L. (2005) · American Journal of Critical Care · doi:10.4037/ajcc2005.14.6.555 · Cited by 2
Statin treatment and the risk of recurrent pulmonary embolism
Ray, K. K. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht124 · Cited by 2
Statins Therapy may Change a Course of Lung Fibrosis and Pulmonary Hypertension: A New Indication for Therapy or Just “Statinomania”?
Kotyla, P. J. (2009) · Current Respiratory Medicine Reviews · doi:10.2174/157339809787354029 · Cited by 1
Statins for Treatment of Pulmonary Hypertension
Faul, J. L., Kao, P. N., Nishimura, T., Sung, A. W., Hu, H., & Pearl, R. G. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-075-5_15 · Cited by 1
Oxidised Low Density Lipoprotein (LDL) Modification with Statin Therapy is Associated with Reduction in Carotid Stenosis
Skopelitis, E. E., Levisianou, D., Lydataki, H., & Kougialis, S. (2014) · InTech eBooks · doi:10.5772/57188 · Cited by 2
Evaluation of Pleiotropic Effects of Statins in Chronic Renal Failure Patients
Özkurt, S., Soydan, M., Şahin, G., Bal, C., & Alataş, Ö. (2011) · Turkish Journal of Nephrology · doi:10.5262/tndt.2011.1002.06 · Cited by 1
Efectos de pravastatina en la disfunción endotelial, estrés oxidativo y otros parámetros cardiovasculares
Kassan, M. (2010) · doi:10.14201/gredos.83206 · Cited by 1
Oxidized Low Density Lipoprotein, Statin Therapy and Carotid Stenosis
Skopelitis, E. E., Levisianou, D., Gialernios, T., & Kougialis, S. (2012) · InTech eBooks · doi:10.5772/25833
Current Therapy Targeting Oxidative Stress: Statin
Nistala, R., & Whaley‐Connell, A. T. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-857-7_18
Estatinas y disfunción endotelial
Carrasco, O. F., & Vidrio, H. (2006)
Interaction of the HMG-CoA Reductase Inhibitor Lovastatin and Nitric Oxide in Cardiomyocyte Cell Death
Rabkin, S. W., & Tsang, M. (2008) · Pharmacology · doi:10.1159/000134380
Molecular mechanisms of statin-induced myotoxicity
Mullen, P. (2011) · edoc (University of Basel) · doi:10.5451/unibas-005591169
Anti-Inflammatory and Antioxidant Functions of High Density Lipoproteins
Moore, R. E., & Rader, D. J. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-387-29553-4_17
The INTERHEART Study: New data on global risk
Colleague, D., & Pepine, C. J. (2004)
Estatinas y sus efectos sistémicos más allá del control del colesterol
Médica, R. (2009)
Effect of Simvastatin, Hydrochlorothiazide and Combined Treatment on Bone Formation and Lipid Profile of Corticosteroid-Induced Osteoporosis in Albino Rats
Kumosani, T. A., Ahmad, M. A. A. A. S., Qari, M. H., & Amin, H. (2018) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2018/40943
CHOLESTEROL REGULATION OF PULMONARY ENDOTHELIAL CALCIUM ENTRY FOLLOWING CHRONIC HYPOXIA
Zhang, B. (2017) · UNM’s Digital Repository (University of New Mexico)
Statin-Induced Diplopia: A Rare Side Effect
Ganason, A. S., Suluraju, C., Paimin, F., Yahaya, Y., & Mohideen, F. B. S. (2021) · Malaysian Journal of Science Health & Technology · doi:10.33102/mjosht.v7i3.181
Precious Wetlands Rapidly Disappearing
Sato, H. (2006)
Pathophysiology of cardiovascular events in Bcr/Abl-negative myeloproliferative neoplasms
Poisson, J. (2018) · theses.fr (ABES) · doi:10.70675/d71df373z8cc7z41c1z9896zab996bc5b48e
Development and validation of a machine learning-based model for predicting amputation risk in patients with lower extremity arterial disease and diabetes
Tang, L., Wang, L., Li, J., Liu, X., Chen, Q., Song, P., Quan, X., Li, Q., Liu, G., Liu, Y., et al. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1893875

Authors: Mason, R. P., Walter, M. F., & Jacob, R. F.
Affiliations: From the Cardiovascular Division, Department of Medicine (R.P.M.), Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass; and the Cardiovascular Research Group (R.P.M., M.F.W., R.F.J.), Elucida Research LLC, Beverly, Mass.
Brigham and Women's Hospital (US)
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2004-06
Volume: 109
Issue: 21_suppl_1
Pages: II34-41
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/01.cir.0000129503.62747.03
OpenAlex: W2148580947
Cited by: 175
References: 82
Citations by year: 2026: 2 · 2025: 1 · 2024: 3 · 2022: 1 · 2021: 8 · 2020: 6 · 2019: 4 · 2018: 3 · 2017: 8 · 2016: 5 · 2015: 8 · 2014: 9 · 2013: 9 · 2012: 6
FWCI: 10.85
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: American Heart Association
Pfizer
National Heart, Lung, and Blood Institute
National Eye Institute
Topics: Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords: statins, endothelial function, nitric oxide bioavailability, endothelial nitric oxide synthase, lipid rafts, cholesterol biosynthesis, terpenoids, cholesterol crystals, oxidative stress, reactive oxygen species, endothelial cell apoptosis, plaque stabilization
MeSH terms: Animals, Arteriosclerosis, Cholesterol, Crystallization, Endothelium, Vascular, Humans, Nitric Oxide, Oxidative Stress, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Membrane Microdomains

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effects of HMG-CoA Reductase Inhibitors on Endothelial Function: Role of Microdomains and Oxidative Stress

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks